A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Seattle Children's Hospital
St. Jude Children's Research Hospital
Hadassah Medical Organization
British Columbia Cancer Agency
Children's National Research Institute
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
St. Jude Children's Research Hospital
Celgene
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Vanderbilt University
Indiana University
University of Minnesota
Children's Oncology Group
Children's Oncology Group
Mayo Clinic
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Roswell Park Cancer Institute
Northwestern University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center